Capital International Investors 13D/13G Filings for Agios Pharmaceuticals, Inc. (AGIO)

Capital International Investors 13D and 13G filings for Agios Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-11-09
8:26 pm
Sale
2020-11-1013GAgios Pharmaceuticals, Inc.
AGIO
Capital International Investors220,510
0.300%
-4,428,964decrease
(-95.26%)
Filing